基于PET/CT与增强CT影像组学及临床变量的机器学习分析无创预测胃癌脉管侵犯
回顾性纳入101例接受手术的胃癌患者,经病理确认脉管侵犯(LVI)状态,随机分为训练集76例与验证集25例,从PET及静脉期CT图像提取影像组学特征,结合临床因素用AdaBoost、LDA和LR三种分类器构建临床模型、图像模型与联合模型。验证集中联合模型AUC分别为0.944、0.929、0.921,优于图像模型和临床模型,且校准良好、临床有用。
要点
- 联合PET/CT与增强CT影像组学及临床因素的机器学习模型在验证集预测胃癌LVI的AUC达0.921–0.944。
- 图像模型验证集AUC为0.778–0.849,临床模型验证集AUC为0.690–0.742。
- 模型基于术前影像无创预测LVI,作者认为可辅助胃癌手术决策。
核心结论
- 基于PET/CT与增强CT影像组学特征及临床因素的机器学习模型对胃癌LVI具有良好区分能力,可作为无创术前预测工具并辅助手术决策。
研究设计与样本
- 回顾性纳入101例接受手术的胃癌患者,LVI状态经病理分析确认,随机分为训练集76例和验证集25例。
- 对PET图像及静脉期CT图像行3D手动分割并提取影像组学特征。
- 分别用所选增强CT及PET影像组学特征、临床因素及两者组合构建图像模型、临床模型和联合模型。
- 采用AdaBoost、线性判别分析(LDA)和逻辑回归(LR)三种机器学习分类器开发模型,并从区分度、校准和临床实用性评价性能。
诊断标准与关键数值
- 共筛选出10个影像组学特征和8个临床因素用于构建预测模型。
- 验证集中临床模型AUC:AdaBoost 0.742、LDA 0.706、LR 0.690。
- 验证集中图像模型AUC:AdaBoost 0.849、LDA 0.778、LR 0.810。
- 验证集中联合模型AUC:AdaBoost 0.944、LDA 0.929、LR 0.921,联合模型性能优于图像模型和临床模型,且校准良好、临床有用。
临床应用与阅片要点
- 作者认为联合PET/CT与增强CT影像组学及临床因素的机器学习模型可用于胃癌LVI的无创术前预测并辅助手术治疗决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Lymphovascular invasion (LVI) is associated with metastasis and poor survival in patients with gastric cancer, yet the noninvasive diagnosis of LVI is difficult. This study aims to develop predictive models using different machine learning (ML) classifiers based on both enhanced CT and PET/CT images and clinical variables for preoperatively predicting lymphovascular invasion (LVI) status of gastric cancer.
METHODS: A total of 101 patients with gastric cancer who underwent surgery were retrospectively recruited, and the LVI status was confirmed by pathological analysis. Patients were randomly divided into a training dataset (n = 76) and a validation dataset (n = 25). By 3D manual segmentation, radiomics features were extracted from the PET and venous phase CT images. Image models, clinical models, and combined models were constructed by selected enhanced CT-based and PET-based radiomics features, clinical factors, and a combination of both, respectively. Three ML classifiers including adaptive boosting (AdaBoost), linear discriminant analysis (LDA), and logistic regression (LR) were used for model development. The performance of these predictive models was evaluated with respect to discrimination, calibration, and clinical usefulness.
RESULTS: Ten radiomics features and eight clinical factors were selected for the development of predictive models. In the validation dataset, the area under curve (AUC) values of clinical models using AdaBoost, LDA, and LR classifiers were 0.742, 0.706, and 0.690, respectively. The image models using AdaBoost, LDA, and LR classifiers achieved an AUC of 0.849, 0.778, and 0.810, respectively. The combined models showed improved performance than the image models and the clinical models, with the AUC values of AdaBoost, LDA, and LR classifier yielding 0.944, 0.929, and 0.921, respectively. The combined models also showed good calibration and clinical usefulness for LVI prediction.
CONCLUSION: ML-based models integrating PET/CT and enhanced CT radiomics features and clinical factors have good discrimination capability, which could serve as a noninvasive, preoperative tool for the prediction of LVI and assist surgical treatment decisions in patients with gastric cancer.
引用
- Fan, Li, Zhang, et al. Machine learning analysis for the noninvasive prediction of lymphovascular invasion in gastric cancer using PET/CT and enhanced CT-based radiomics and clinical variables. Abdom Radiol (NY). 2022. PMID: 35089370. doi:10.1007/s00261-021-03315-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。